Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$60.85 - $83.98 $365,100 - $503,880
-6,000 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$83.06 - $100.98 $498,360 - $605,880
6,000 New
6,000 $500,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Yong Rong (Hk) Asset Management LTD Portfolio

Follow Yong Rong (Hk) Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yong Rong (Hk) Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Yong Rong (Hk) Asset Management LTD with notifications on news.